(Q36198492)

12 August 2017

1 reference

title

C5b-9 complement complex in autoimmune demyelination and multiple sclerosis: dual role in neuroinflammation and neuroprotection (English)

1 reference

12 August 2017

0 references

0 references

Horea Rus

1

1 reference

12 August 2017

Cornelia Cudrici

series ordinal

2

1 reference

12 August 2017

Florin Niculescu

series ordinal

3

1 reference

12 August 2017

language of work or name

English

0 references

publication date

1 January 2005

1 reference

12 August 2017

1 reference

12 August 2017

37

1 reference

12 August 2017

2

1 reference

12 August 2017

97-104

1 reference

Immunopathogenesis of the multiple sclerosis lesion

12 August 2017

1 reference

https://api.crossref.org/works/10.1080%2F07853890510007278

Complement activation by isolated myelin: activation of the classical pathway in the absence of myelin-specific antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890510007278

Oligodendrocytes and oligodendrocyte/type-2 astrocyte progenitor cells of adult rats are specifically susceptible to the lytic effects of complement in absence of antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890510007278

MASP-3 and its association with distinct complexes of the mannan-binding lectin complement activation pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890510007278

Membrane damage by complement

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890510007278

Antibody-independent complement activation by myelin via the classical complement pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890510007278

Myelin vesicles as an in vitro model to study mechanisms of myelin damage by immune effectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890510007278

The complement system in central nervous system diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890510007278

Mechanisms of demyelination and tissue destruction in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890510007278

Complement C5 in experimental autoimmune encephalomyelitis (EAE) facilitates remyelination and prevents gliosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890510007278

Effects of complement C5 on apoptosis in experimental autoimmune encephalomyelitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890510007278

Intrathecal activation of the complement system and disability in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890510007278

Immunocytochemical localization of the terminal complement complex in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890510007278

Multiple sclerosis: in situ evidence for antibody- and complement-mediated demyelination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890510007278

Relapsing and remitting multiple sclerosis: pathology of the newly forming lesion

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890510007278

Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890510007278

Vesicular removal by oligodendrocytes of membrane attack complexes formed by activated complement

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890510007278

10.1080/07853890510007278

21 January 2018

Identifiers

DOI

1 reference

12 August 2017

1 reference